Alzheimer's, Tau Protein
New Alzheimer's Treatment Shows Promise by Dual-Targeting Tau Protein
AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to Alzheimer's disease. Early tests demonstrated the drug's effectiveness in reducing tau aggregation.
Promising New Alzheimer’s Treatment Eradicates Tau Tangles
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader application in neurodegenerative diseases. Researchers have developed promising new therapies that selectively target and destroy aggregated tau proteins,
Alzheimer’s breakthrough after drug treatment success
Alzheimer’s breakthrough after drug treatment success - The study found that the medication, called RI-AG03, was effective at preventing the build-up of Tau proteins
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
Researchers say they have sparked an “exciting” breakthrough in treating Alzheimer’s disease by developing a drug to prevent the build-up of toxic proteins in the brain. “This research is taking promising steps toward a new one-of-a-kind therapy which targets tau,
Breakthrough Alzheimer’s Drug Prevents Toxic Protein Build-up In Brain
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can prevent the build-up of toxic proteins in the brain that lead to neurodegenerative issues causing Alzheimer’s disease.
First-of-its-kind Alzheimer's drug offers hope of treatment
Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to the memory robbing condition getting worse.
New study is a promising ‘first’ in Alzheimer’s drug development
New study is a promising ‘first’ in Alzheimer’s drug development - Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative diseases.
Neuroscience News2d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Hosted on MSN3d
Researchers make breakthrough in Alzheimer's disease drug development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of ...
Medical Xpress3d
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
As more neurons die, memory, thinking, and behavior become increasingly impaired, leading to the cognitive decline seen in Alzheimer's. There are two specific "hotspots" of the tau protein where ...
EuropaWire2d
Breakthrough Peptide Inhibitor Targets Tau Protein Aggregation, Paving the Way for New Alzheimer’s Treatments
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
Science Daily3d
Promising 'first' in Alzheimer's drug development
As more neurons die, memory, thinking, and behaviour become increasingly impaired, leading to the cognitive decline seen in Alzheimer's. There are two specific 'hotspots' of the Tau protein ...
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...